Tauriga Sciences Inc. Generates Record Quarterly E-Commerce Revenue for its 2nd Fiscal Quarter 2021 (Period: July 1 -- September 30, 2020)
Tauriga Sciences, Inc. (TAUG) reported record E-Commerce sales for its 2nd Fiscal Quarter 2021, substantially exceeding the previous record of $62,864.06 set in the 1st Fiscal Quarter 2021. The company remains confident in its growth prospects, supported by a strong fulfillment infrastructure and substantial inventory levels. Additionally, Tauriga continues to see an increase in re-orders from customers. The company engages in the CBD and CBG edibles market, with its main product line being Tauri-Gum™, and is working on biotechnology initiatives, including a pharmaceutical version for chemotherapy patients and a COVID-19 testing collaboration.
- Record E-Commerce sales surpassing previous high of $62,864.06.
- Strong fulfillment infrastructure capable of supporting significant growth.
- Substantial inventory on hand across all product lines.
- Increasing number of re-orders from E-Commerce and Retail customers.
- None.
The Company Substantially Exceeds its Previous Quarterly Record, of
NEW YORK, NY, Oct. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire-- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that its highest margin business segment (E-Commerce), continues to demonstrate meaningful levels of growth, momentum, and overall strength. For its 2ndFiscal Quarter 2021 (Period: July 1 – September 30, 2020), the Company generated record Quarterly sales – with respect to its E-Commerce sales. The Company is confident that its existing fulfillment infrastructure can handle significant levels of additional growth, should that occur. The Company has substantial levels of inventory on hand, for all of its products and product lines (fully paid for).
The Company remains highly confident in its future growth prospects and continues to receive an increasing number of re-orders from both E-Commerce and Retail customers.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is both Kosher certified and Vegan formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused Tauri-Gum™ Flavor: Peach-Lemon). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives. The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.
The Company is headquartered in New York City and operates a regional office in Barcelona, Spain. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
CONTACT:
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Attachment
FAQ
What were Tauriga Sciences' E-Commerce sales for the 2nd Fiscal Quarter 2021?
What is the main product line of Tauriga Sciences?
What initiatives is Tauriga Sciences currently pursuing?
How is Tauriga Sciences' fulfillment infrastructure?
